Literature DB >> 24083713

The synergistic anticancer effect of artesunate combined with allicin in osteosarcoma cell line in vitro and in vivo.

Wei Jiang1, Yong Huang, Jing-Peng Wang, Xiao-Yun Yu, Lin-Yi Zhang.   

Abstract

BACKGROUND: Artesunate, extracted from Artemisia annua, has been proven to have anti-cancer potential. Allicin, diallyl thiosulfinate, the main biologically active compound derived from garlic, is also of interest in cancer treatment research. This object of this report was to document synergistic effects of artesunate combined with allicin on osteosarcoma cell lines in vitro and in vivo.
METHODS: After treatment with artesunate and allicin at various concentrations, the viability of osteosarcoma cells was analyzed by MTT method, with assessment of invasion and motility, colony formation and apoptosis. Western Blotting was performed to determine the expression of caspase-3/9, and activity was also detected after drug treatment. Moreover, in a nude mouse model established with orthotopic xenograft tumors, tumor weight and volume were monitored after drug administration via the intraperitoneal (i.p.) route.
RESULTS: The viability of osteosarcoma cells in the combination group was significantly decreased in a concentration and time dependent manner; moreover, invasion, motility and colony formation ability were significantly suppressed and the apoptotic rate was significantly increased through caspase-3/9 expression and activity enhancement in the combination group. Furthermore, suppression of tumor growth was evident in vivo.
CONCLUSION: Our results indicated that artesunate and allicin in combination exert synergistic effects on osteosarcoma cell proliferation and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24083713     DOI: 10.7314/apjcp.2013.14.8.4615

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  19 in total

1.  MicroRNA-26a induces osteosarcoma cell growth and metastasis via the Wnt/β-catenin pathway.

Authors:  Feng Qu; Chun-Bao Li; Bang-Tuo Yuan; Wei Qi; Hong-Liang Li; Xue-Zhen Shen; Gang Zhao; Jiang-Tao Wang; Yu-Jie Liu
Journal:  Oncol Lett       Date:  2015-12-31       Impact factor: 2.967

2.  Artesunate attenuates unilateral ureteral obstruction-induced renal fibrosis by regulating the expressions of bone morphogenetic protein-7 and uterine sensitization-associated gene-1 in rats.

Authors:  Jing Cao; Wei Wang; Yong Li; Jieyun Xia; Yingxian Peng; Yaqian Zhang; Anzhou Xia
Journal:  Int Urol Nephrol       Date:  2016-02-10       Impact factor: 2.370

3.  Hypoxic conditions increases H₂S-induced ER stress in A2870 cells.

Authors:  Lubomira Lencesova; Miroslav Vlcek; Olga Krizanova; Sona Hudecova
Journal:  Mol Cell Biochem       Date:  2016-02-11       Impact factor: 3.396

4.  Artesunate inhibits melanoma progression in vitro via suppressing STAT3 signaling pathway.

Authors:  Mehmet Berköz; Ferbal Özkan-Yılmaz; Arzu Özlüer-Hunt; Mirosław Krośniak; Ömer Türkmen; Duygu Korkmaz; Sıddık Keskin
Journal:  Pharmacol Rep       Date:  2021-02-20       Impact factor: 3.024

5.  Allicin, a Potent New Ornithine Decarboxylase Inhibitor in Neuroblastoma Cells.

Authors:  Chad R Schultz; Martin C H Gruhlke; Alan J Slusarenko; André S Bachmann
Journal:  J Nat Prod       Date:  2020-08-12       Impact factor: 4.803

6.  Allicin Alleviates Dextran Sodium Sulfate- (DSS-) Induced Ulcerative Colitis in BALB/c Mice.

Authors:  Ashok Kumar Pandurangan; Salmiah Ismail; Zeinab Saadatdoust; Norhaizan Mohd Esa
Journal:  Oxid Med Cell Longev       Date:  2015-05-05       Impact factor: 6.543

7.  Artesunate suppresses tumor growth and induces apoptosis through the modulation of multiple oncogenic cascades in a chronic myeloid leukemia xenograft mouse model.

Authors:  Chulwon Kim; Jong Hyun Lee; Sung-Hoon Kim; Gautam Sethi; Kwang Seok Ahn
Journal:  Oncotarget       Date:  2015-02-28

8.  CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide.

Authors:  Richard E Kast; Georg Karpel-Massler; Marc-Eric Halatsch
Journal:  Oncotarget       Date:  2014-09-30

9.  Allicin attenuates tunicamycin-induced cognitive deficits in rats via its synaptic plasticity regulatory activity.

Authors:  Qiong Xiang; Xian-Hui Li; Bo Yang; Xin-Xing Fang; Jing Jia; Jie Ren; Yu-Chun Dong; Cheng Ou-Yang; Guang-Cheng Wang
Journal:  Iran J Basic Med Sci       Date:  2017-06       Impact factor: 2.699

Review 10.  Advances in Synergistic Combinations of Chinese Herbal Medicine for the Treatment of Cancer.

Authors:  Xue-Qing Hu; Yang Sun; Eric Lau; Ming Zhao; Shi-Bing Su
Journal:  Curr Cancer Drug Targets       Date:  2016       Impact factor: 3.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.